TYRUOS FINANCE
Opening research…
Retrieving research data…
Workspace/Market
TYRUOS FINANCE
21.40NOK
-0.40 (-1.83%)
Sandbox quote · 11 Sept, 14:30 UTC
Daily closing prices returned by the sandbox.
| Date | Close | Volume |
|---|---|---|
| 10 Sept 2026 | 21.90 | 14,974 |
| 8 Sept 2026 | 21.90 | 14,974 |
| 7 Sept 2026 | 23.10 | 57,939 |
| 6 Sept 2026 | 14.80 | 10,088 |
| 5 Sept 2026 | 14.79 | 22,650 |
| 4 Sept 2026 | 14.65 | 18,704 |
| 3 Sept 2026 | 14.80 | 12,404 |
| 2 Sept 2026 | 14.80 | 34,649 |
| 30 Aug 2026 | 15.25 | 107,681 |
| 29 Aug 2026 | 13.70 | 15,655 |
| 28 Aug 2026 | 13.70 | 5,219 |
| 27 Aug 2026 | 13.71 | 5,523 |
| 26 Aug 2026 | 14.00 | 8,184 |
| 23 Aug 2026 | 13.95 | 4,262 |
| 22 Aug 2026 | 14.00 | 1,454 |
| 21 Aug 2026 | 13.90 | 3,201 |
| 20 Aug 2026 | 13.40 | 5,693 |
| 19 Aug 2026 | 13.95 | 14,619 |
| 16 Aug 2026 | 14.00 | 30,461 |
| 13 Aug 2026 | 13.80 | 23,215 |
| 12 Aug 2026 | 14.40 | 35,977 |
| 6 Aug 2026 | 14.70 | 81,639 |
| 5 Aug 2026 | 15.39 | 94,178 |
| 2 Aug 2026 | 15.00 | 137,698 |
| 1 Aug 2026 | 15.30 | 378,909 |
| 31 Jul 2026 | 11.90 | 33,115 |
| 30 Jul 2026 | 11.20 | 174,098 |
| 29 Jul 2026 | 10.34 | 39,755 |
| 26 Jul 2026 | 9.50 | 52,786 |
| 25 Jul 2026 | 9.24 | 7,163 |
| 24 Jul 2026 | 9.30 | 1,266 |
| 23 Jul 2026 | 9.30 | 12,355 |
| 22 Jul 2026 | 9.28 | 22,356 |
| 19 Jul 2026 | 9.37 | 16,374 |
| 18 Jul 2026 | 9.25 | 1,619 |
| 17 Jul 2026 | 9.05 | 6,315 |
| 16 Jul 2026 | 8.65 | 12,602 |
| 15 Jul 2026 | 8.70 | 8,149 |
| 12 Jul 2026 | 9.00 | 11,422 |
| 11 Jul 2026 | 8.80 | 5,499 |
| 10 Jul 2026 | 9.10 | 11,239 |
Sandbox observations are not verified live market data.
Historical adjustments are unverified: the sandbox returned inconsistent series for adjustment options.
Sandbox source dates can reflect replayed data and conflict with modification or original document dates.
Ultimovacs is a Norwegian pharmaceutical company. The company's business focus is to develop immunotherapies for various cancer conditions. Research and development are based on a self-based technological platform, where the products are mainly further developed as vaccines. The largest presence is in Europe and North America. Ultimovacs was founded in 2011 and is headquartered in Oslo.
Millistream MWS sandbox · Retrieved 11 Sept, 19:40 UTC
Market capitalisation
629.45mNOK
Sandbox quote snapshot
Day volume
8.22k
Reported traded quantity
Day range
21.30–21.90
NOK · Low to high
Previous close
21.80NOK
Provider-reported reference
What the returned data says, and what it cannot tell you. Sandbox data; every card links to its evidence.
What moved
-1.83%
Last 21.40 NOK · previous close 21.80
Volume 8.22k · market cap 629.45m
Radforsk Investeringsstiftelse
9.00% of capital · 9.00% of votes
Top 5 returned holders: 34.70% of capital
Radforsk Investeringsstiftelse
Others with Insider Information
Other / unclassified · +2,469,693
News
Zelluna Submits Clinical Trial Application to UK MHRA for First-in-Human TCR-NK Cell Therapy
Data coverage